Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Antivir Ther. 2010;15(3 Pt B):499-503. doi: 10.3851/IMP1494.

HIV-HBV coinfection among South African patients receiving antiretroviral therapy.

Author information

  • 1Department of Internal Medicine, Saint Louis University, St Louis, MO, USA. dibiscam@slu.edu

Abstract

There are approximately 33 million individuals with HIV infection worldwide. The majority of infections are in southern Africa where hepatitis B is also known to be endemic. As access to life-saving antiretroviral therapy (ART) increases, the possibility for hepatitis B treatment resistance increases because most ART regimens contain lamivudine. Patients coinfected with HBV are therefore receiving monotherapy for HBV infection, leading to possible HBV-resistant mutants and the concurrent public health effect thereof. Additional information is needed on the prevalence of HIV-HBV coinfection and treatment response to ART. We present a summary of the information available from South Africa to date.

PMID:
20516571
[PubMed - indexed for MEDLINE]
PMCID:
PMC3001165
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Write to the Help Desk